Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425437 · ClinicalTrials.gov registry record
Keloid Tissue Bank
A clinical trial, sponsored by Tirgan, Michael H., M.D..
- Terminated
- Registry status
- 78
- Enrollment target
NCT01425437: Clinical Trial study, sponsored by Tirgan, Michael H., M.D..
NCT01425437 is a clinical trial that was terminated before completion, run by Tirgan, Michael H., M.D.. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01425437 was terminated before completion, sponsored by Tirgan, Michael H., M.D..
- TERMINATED
- Registry status
- 78 participants
- Enrollment target
Study Summary
Much progress in treatment of various tumors has been made in the laboratory and the results have been brought back to the patients, i.e. from bench to bedside. This trial intends to collect samples of keloid tissue from patients and study them in laboratory. Such a research may help us with finding better treatments for keloid.
Primary Outcome
Prevalence of various biomarkers and/or mutations will be determined and co-related with the clinical presentation of the disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2012-06 |
| Est. Completion | 2018-12 |
Why NCT01425437 stopped before completion
NCT01425437 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01425437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01425437 about?
NCT01425437 is a clinical study titled "Keloid Tissue Bank". Much progress in treatment of various tumors has been made in the laboratory and the results have been brought back to the patients, i.e. from bench to bedside. This trial intends to collect samples of keloid tissue from patients and study them in laboratory. Such a research may help us with finding...
What is the current status of trial NCT01425437?
This trial is currently terminated. The enrollment target is 78 participants. The study started on 2012-06. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01425437?
This trial is sponsored by Tirgan, Michael H., M.D., which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia